abramsci_logo.png

Fast hemostasis information for improved outcomes

CoagCare Platform

01 / FAST

Less than 5-10 minutes 

from insertion of sample (approx. 20 microliters) to

full viscoelastic curve and parameter generation

02 / PORTABLE

Low-cost, single-use diagnostic test strips that interface with a wireless, handheld meter that is vibration-insensitive

03 / ACCURATE

Mechanical viscoelasticity and density measurement for blood coagulation diagnostics

CoagCare meter and disposable.png

CoagCare / PLATFORM CAPABILITIES*

 

  • Thromboelastography

    • Clot Formation Time​

    • Clot Stiffness (Fibrinogen)

    • Platelet Activity

    • Fibrinolysis

  • Thrombin Generation Assay

  • Direct Oral Anticoagulants (DOAC) Monitoring (including Factor IIa and Xa drug differentiation)

  • Prothrombin Time (PT) / International Normalized Ratio (INR)

  • Hematocrit (Hct)

  • Activated Partial Thromboplastin Time (aPTT)

  • Low- and High-range Activated Clotting Time (ACT)

 

* feasibility demonstrated ​on clinical & analytical blood samples

 
 

COVID-19

Coagulopathy is a major cause of death in COVID-19 patients

Viscoelastic tests can accurately detect and manage Coagulopathy

Critical need for fast, point-of-care (POC) viscoelastic tests to:

  • Quickly screen for coagulopathy in asymptomatic and symptomatic COVID-19 patients.
     

  • Provide closed-loop therapeutic management in ambulatory, inpatient and outpatient settings.​

 ​ Abram Scientific is engaging with frontline physicians at leading ER and trauma centers to address this critical need using the CoagCare platform.

ABOUT US

Edward Brennan

Chief Executive Officer

James Merselis

Chairman of the Board

Albert Di Rienzo

Board Member

Abhishek Ramkumar

President, Founder

David Merselis

VP Engineering

We are hiring!

Check out our Careers page or LinkedIn.

 
 
 

GET IN TOUCH

CONTACT US

Thanks for your message! We will get in contact with you shortly.